Biotech · Private company · Albany, NY, US
Albany Molecular Research, Inc.
Track this companyFree. Adds Albany Molecular Research, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- KATRITCH- UNIVERSITY OF SOUTHERN CALIFORNIA DMFP FOR BPN-35269 - CURIA GLOBAL, INC.Fiscal year 2026 · $992.3KNIH RePORTER 271201500005I-P00002-759502300001-1 · fetched Nov 12, 2026
- EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137Fiscal year 2026 · $2.1MNIH RePORTER 271201800001I-0-759802600001-1 · fetched Nov 12, 2026
- EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137.Fiscal year 2026 · $692.2KNIH RePORTER 271201800001I-0-759802600002-1 · fetched Nov 12, 2026
- EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137.Fiscal year 2026 · $669.2KNIH RePORTER 271201800001I-0-759802600003-1 · fetched Nov 12, 2026
- IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSPFiscal year 2026 · $21.1KNIH RePORTER 271201800001I-P00009-27100001-1 · fetched Nov 12, 2026
- NINDS Drug Manufacturing and Formulation Program (DMFP) KickoffFiscal year 2026 · $5KNIH RePORTER 75N98026D00013-0-759802600001-1 · fetched Nov 12, 2026
- BPN PROJECT BPN-36938Fiscal year 2025 · $1.4MNIH RePORTER 271201500005I-P00001-759502400001-1 · fetched Nov 12, 2026
- CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIALFiscal year 2025 · $82.6KNIH RePORTER 271201700005I-P00002-759502300001-1 · fetched Nov 12, 2026
- BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO)Fiscal year 2025 · $922.3KNIH RePORTER 271201800001I-0-759502500001-1 · fetched Nov 12, 2026
- HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001IFiscal year 2025 · $611.1KNIH RePORTER 271201800001I-P00003-759502200007-1 · fetched Nov 12, 2026